Global Contract Cell and Gene Therapy Manufacturing Market Highlights
| Market Size (2025) | USD 3.8 Billion |
| Forecast Size (2032) | USD 10.9 Billion |
| CAGR | 5.40% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Viral Vector |
| Fastest Growing Segment | Non-viral Vector |
| Leading Companies | Lonza, WuXi AppTec, Thermo Fisher Scientific, Catalent, Cellectis |
Global Contract Cell and Gene Therapy Manufacturing Market Size & Growth Rate (2026-2032)
The Global Contract Cell and Gene Therapy Manufacturing Market was estimated at USD 3.8 Billion in 2025 and is projected to reach USD 10.9 Billion by 2032, growing at a CAGR of 5.40% from 2026 to 2032.
Global Contract Cell and Gene Therapy Manufacturing Market Synopsis
The Global Contract Cell and Gene Therapy Manufacturing Market is transforming due to increased outsourcing trends among biopharmaceutical companies. Contract manufacturing organizations (CMOs) are gaining traction as these companies seek specialized support for complex production processes essential for innovative therapies. This shift underscores the critical role of CMOs in navigating regulatory hurdles and enhancing production efficacy in a rapidly evolving landscape.
Recent developments in personalized medicine are pushing the boundaries of cell and gene therapies. Innovations in manufacturing techniques have resulted in more cost-effective and scalable production solutions. As a result, numerous sectors are repositioning their strategies to accommodate the growing requirement for bespoke therapies tailored to individual patient needs.
Global Contract Cell and Gene Therapy Manufacturing Market Year-wise Growth Rate and Key Drivers
This graph illustrates the annual growth rates of the Global Contract Cell and Gene Therapy Manufacturing Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.
The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 16.77 | Manufacturers are adapting strategies to navigate a shifting competitive environment in gene therapy. |
| 2023 | 16.31 | In North America, rising raw material prices are affecting cell therapy manufacturing costs. |
| 2024 | 17.22 | Adoption of personalized medicine is changing patient perspectives on gene therapy treatments. |
| 2025 | 16.4 | Pharmaceutical companies are expanding their contracts for cell therapy manufacturing across Europe. |
| 2026 | 17.38 | A fragmented supply chain is creating challenges for efficient gene therapy production. |
| 2027 | 16.41 | Implementing sustainable practices is driving improvements in contract manufacturing processes for therapies. |
| 2028 | 14.3 | Wearable monitoring devices are increasingly integral to patient management in gene therapy applications. |
| 2029 | 17.54 | Mergers and acquisitions among biotech firms are enhancing capabilities in gene therapy manufacturing. |
| 2030 | 14.47 | Contract manufacturers are incorporating advanced drug delivery systems to enhance therapy outcomes. |
| 2031 | 20.17 | As patient demand for effective gene therapies increases, production capacities are being expanded. |
| 2032 | 13.59 | A shift toward stricter FDA regulations alters the compliance landscape for gene therapy manufacturers. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Global Contract Cell and Gene Therapy Manufacturing Market Key Takeaways
Below are some of the specific key takeaways from the market, including:
- Viral vector technologies are anticipated to dominate the market, commanding approximately ~53% share in 2025.
- The ongoing collaborations between CMOs and biopharma firms are expected to grow by 20% in the next three years.
- Asia is predicted to be the fastest-growing region, with a projected CAGR of 7.2% from 2026 to 2032.
- The production capabilities of leading companies like Lonza have increased by 30% to meet the demand from cell and gene therapy pipelines.
Evaluation of Restraints in Global Contract Cell and Gene Therapy Manufacturing Market
The Global Contract Cell and Gene Therapy Manufacturing Market faces significant challenges, primarily due to the strict regulatory environment governing cell and gene therapies. For instance, compliance with Good Manufacturing Practices (GMP) can cost manufacturers upwards of $1 million for facility validation. This financial burden often deters smaller firms from entering the market. Additionally, regulatory approvals can take several years, creating bottlenecks that hinder timely production and delivery. For example, the extended FDA approval process for novel gene therapies can result in delays that disrupt project timelines and financing.
Global Contract Cell and Gene Therapy Manufacturing Market Trends
Several trends are significantly shaping the Global Contract Cell and Gene Therapy Manufacturing Market. Firstly, there is a marked shift toward automation within CMOs, enhancing production efficiency and scalability. Companies like WuXi AppTec are investing heavily in automated systems, which have demonstrated a reduction in labor costs by approximately 25% over the past few years. Secondly, increased use of digital technologies, such as artificial intelligence, is expected to streamline quality control and regulatory compliance processes, minimizing human error. For instance, companies adopting AI-driven analytics have reported reduced time-to-market for new therapies by as much as 15%.
Global Contract Cell and Gene Therapy Manufacturing Market Opportunities
The Global Contract Cell and Gene Therapy Manufacturing Market presents several lucrative opportunities. Collaborative initiatives between CMOs and key biopharmaceutical firms like Catalent are focusing on advanced therapies, positioning both parties for market expansion. An example includes Catalent's recent investment of $200 million to enhance its manufacturing capabilities specifically for gene therapies. Furthermore, there is a growing opportunity in the medical device sector, where innovations in combination drug-device products are expected to increase revenue streams for CMOs. Projects integrating cell therapies with diagnostic devices are expected to contribute significantly to market growth.
Global Contract Cell and Gene Therapy Manufacturing Market by Vector
The leading vector type in the Global Contract Cell and Gene Therapy Manufacturing Market is the Viral Vector, accounting for approximately ~53% share in 2025. Conversely, the Non-viral Vector segment is expected to experience a CAGR of 6.5% from 2026 to 2032, making it the fastest-growing sector. The preference for viral vectors is attributed to their proven efficacy in delivering therapeutic genes, while non-viral vectors are gaining traction due to reduced manufacturing costs and scalability advantages.
Global Contract Cell and Gene Therapy Manufacturing Market by Indication
Cancer therapies represent the largest indication within the Global Contract Cell and Gene Therapy Manufacturing Market, holding a market share of approximately ~45% as of 2025. Neurological Diseases are anticipated to be the fastest-growing indication, expected to see a CAGR of 7.0% from 2026 to 2032. The increasing incidence rates of cancers and the surge in diagnoses are primarily driving demand in the cancer sector, while the neurological segment benefits from advancements in gene-editing technologies, promoting novel treatment avenues.
Global Contract Cell and Gene Therapy Manufacturing Market by Region
North America is set to dominate the Global Contract Cell and Gene Therapy Manufacturing Market, with an estimated share of ~50% in 2025. This region's leadership stems from its mature biopharmaceutical industry and robust R&D investments. In contrast, Asia is emerging as the fastest-growing region, projected to achieve a CAGR of 7.2% from 2026 to 2032, fueled by increased investments in healthcare infrastructure and a growing focus on personalized medicine to address local patient needs.
Government Initiatives in the Global Contract Cell and Gene Therapy Manufacturing Market
The regulatory and policy landscape surrounding the Global Contract Cell and Gene Therapy Manufacturing Market is increasingly dynamic. Governments worldwide are more focused on supporting innovative therapies, facilitating collaborations between public entities and private companies. Initiatives are geared towards addressing manufacturing complexities and ensuring high standards in therapy administration.
- The U.S. Food and Drug Administration (FDA) initiated the “Regenerative Medicine Advanced Therapy” designation in 2017 to expedite development timelines for gene therapies, aiming to streamline regulatory processes.
- The European Commission announced the “Horizon 2020” funding program in 2018 to support R&D in cell and gene therapies, committing over €1 billion to continue encouraging innovations in the sector.
- The National Institutes of Health (NIH) allocated $70 million in 2022 towards funding gene therapy research, specifically targeting rare diseases to enhance the therapeutic solution pipeline.
- In 2023, the National Health Service (NHS) in the UK launched a framework aimed at integrating gene therapy services into routine clinical practice, ensuring regulatory compliance and enhancing patient access.
Future Insights of the Global Contract Cell and Gene Therapy Manufacturing Market
The future of the Global Contract Cell and Gene Therapy Manufacturing Market is likely to witness transformative changes, especially with increasing investments in automation and digital technologies. For instance, recent advancements in AI are projected to streamline manufacturing processes, significantly enhancing efficiency and reducing production times. By 2032, companies like Thermo Fisher Scientific are expected to leverage these innovations to solidify their market positioning, catering to a growing demand for tailored therapies amidst a complex regulatory landscape.
Global Contract Cell and Gene Therapy Manufacturing Market Latest Developments
Recent developments in the Global Contract Cell and Gene Therapy Manufacturing Market showcase strategic maneuvers by leading firms to enhance their capabilities and market presence. The following are notable updates:
- Catalent announced an ongoing expansion project in March 2023 to increase its viral vector manufacturing capacity, responding to the rising demand for gene therapies.
- Lonza is in the process of completing a new facility in 2024 designed for the production of non-viral vectors, which is expected to enhance their production scalability.
- In January 2023, WuXi AppTec launched an automated production line aimed at improving operational efficiency, which is anticipated to cut down overall production costs.
- Thermo Fisher Scientific has recently begun work on a strategic partnership with a biotech firm in early 2023 to co-develop advanced gene therapies, increasing their product portfolio.
Global Contract Cell and Gene Therapy Manufacturing Market Key Players and Industry Positioning
The competitive landscape of the Global Contract Cell and Gene Therapy Manufacturing Market is characterized by a mix of established players and emerging firms, reflecting a fragmented structure. Major companies are diversifying their portfolios through strategic acquisitions and partnerships to enhance their production capabilities and technological expertise.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Lonza | Expertise in biotech processes and capacity for large-scale manufacturing. | Expanding capabilities in non-viral vector production. |
| WuXi AppTec | Strong focus on automation to increase production efficiency. | Leveraging technology for streamlined operations. |
| Thermo Fisher Scientific | Comprehensive product offerings in gene therapy solutions. | Strategic partnerships for co-development of therapies. |
| Catalent | Significant expertise in viral vector manufacturing. | Investing heavily in capacity expansion. |
| Cellectis | Leadership in cutting-edge gene editing technologies. | Driving innovations in CAR-T cell therapies. |
The strategies adopted by these players not only enhance their market competitiveness but also contribute to the overall robustness of the sector, paving the way for future innovations in cell and gene therapies.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year: 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- Global Contract Cell and Gene Therapy Manufacturing Market Outlook
- Market Size of Global Contract Cell and Gene Therapy Manufacturing Market, 2025
- Forecast of Global Contract Cell and Gene Therapy Manufacturing Market, 2032
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Revenues & Volume for the Period 2022-2032
- Global Contract Cell and Gene Therapy Manufacturing Market Trend Evolution
- Global Contract Cell and Gene Therapy Manufacturing Market Drivers and Challenges
- Global Contract Cell and Gene Therapy Manufacturing Price Trends
- Global Contract Cell and Gene Therapy Manufacturing Porter's Five Forces
- Global Contract Cell and Gene Therapy Manufacturing Industry Life Cycle
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Vector for the Period 2022-2032
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Viral Vector for the Period 2022-2032
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Non-viral Vector for the Period 2022-2032
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Indication for the Period 2022-2032
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Cancer for the Period 2022-2032
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Neurological Diseases for the Period 2022-2032
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Herpetological Diseases for the Period 2022-2032
- Historical Data and Forecast of Global Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2022-2032
- Historical Data and Forecast of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Vector for the Period 2022-2032
- Historical Data and Forecast of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Viral Vector for the Period 2022-2032
- Historical Data and Forecast of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Non-viral Vector for the Period 2022-2032
- Historical Data and Forecast of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Indication for the Period 2022-2032
- Historical Data and Forecast of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Cancer for the Period 2022-2032
- Historical Data and Forecast of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Neurological Diseases for the Period 2022-2032
- Historical Data and Forecast of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Herpetological Diseases for the Period 2022-2032
- Historical Data and Forecast of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2022-2032
- Historical Data and Forecast of United States of America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of North America Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Vector for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Viral Vector for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Non-viral Vector for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Indication for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Cancer for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Neurological Diseases for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Herpetological Diseases for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2022-2032
- Historical Data and Forecast of Brazil Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Argentina Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of LATAM Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Vector for the Period 2022-2032
- Historical Data and Forecast of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Viral Vector for the Period 2022-2032
- Historical Data and Forecast of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Non-viral Vector for the Period 2022-2032
- Historical Data and Forecast of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Indication for the Period 2022-2032
- Historical Data and Forecast of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Cancer for the Period 2022-2032
- Historical Data and Forecast of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Neurological Diseases for the Period 2022-2032
- Historical Data and Forecast of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Herpetological Diseases for the Period 2022-2032
- Historical Data and Forecast of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2022-2032
- Historical Data and Forecast of China Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Japan Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of Asia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Vector for the Period 2022-2032
- Historical Data and Forecast of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Viral Vector for the Period 2022-2032
- Historical Data and Forecast of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Non-viral Vector for the Period 2022-2032
- Historical Data and Forecast of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Indication for the Period 2022-2032
- Historical Data and Forecast of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Cancer for the Period 2022-2032
- Historical Data and Forecast of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Neurological Diseases for the Period 2022-2032
- Historical Data and Forecast of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Herpetological Diseases for the Period 2022-2032
- Historical Data and Forecast of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2022-2032
- Historical Data and Forecast of South Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Nigeria Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Egypt Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of Africa Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Vector for the Period 2022-2032
- Historical Data and Forecast of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Viral Vector for the Period 2022-2032
- Historical Data and Forecast of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Non-viral Vector for the Period 2022-2032
- Historical Data and Forecast of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Indication for the Period 2022-2032
- Historical Data and Forecast of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Cancer for the Period 2022-2032
- Historical Data and Forecast of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Neurological Diseases for the Period 2022-2032
- Historical Data and Forecast of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Herpetological Diseases for the Period 2022-2032
- Historical Data and Forecast of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2022-2032
- Historical Data and Forecast of United Kingdom Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of France Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Germany Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of Europe Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Vector for the Period 2022-2032
- Historical Data and Forecast of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Viral Vector for the Period 2022-2032
- Historical Data and Forecast of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Non-viral Vector for the Period 2022-2032
- Historical Data and Forecast of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Indication for the Period 2022-2032
- Historical Data and Forecast of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Cancer for the Period 2022-2032
- Historical Data and Forecast of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Neurological Diseases for the Period 2022-2032
- Historical Data and Forecast of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Herpetological Diseases for the Period 2022-2032
- Historical Data and Forecast of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2022-2032
- Historical Data and Forecast of Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of UAE Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Turkey Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of Middle East Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume for the Period 2022-2032
- Global Contract Cell and Gene Therapy Manufacturing Market - Key Performance Indicators
- Global Contract Cell and Gene Therapy Manufacturing Market - Import Export Trade Statistics
- Global Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment By Countries
- Global Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment By Vector
- Global Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment By Indication
- Global Contract Cell and Gene Therapy Manufacturing Market - Top Companies Market Share
- Global Contract Cell and Gene Therapy Manufacturing Market - Top Companies Profiles
- Global Contract Cell and Gene Therapy Manufacturing Market - Comparison of Players in Technical and Operating Parameters
- Global Contract Cell and Gene Therapy Manufacturing Market - Strategic Recommendations
Markets Covered
The Global Contract Cell and Gene Therapy Manufacturing Market report provides a detailed analysis of the following market segments:
By Regions and Countries:
- North America
- Europe
- LATAM
- Middle East
- Asia
- Africa
By Vector:
- Viral Vector
- Non-viral Vector
By Indication:
- Cancer
- Neurological Diseases
- Herpetological Diseases
- Others
